$0.643
-0.0072 (-1.11%)
At Close: Jul 31, 2026
The Dividend Aristocrats No One's Talking About (And Their 30+ Year Track Records)
03:40pm, Thursday, 08'th Jan 2026
Dividend aristocrats get plenty of attention, but most of the time the spotlight falls on the big names like Johnson & Johnson (NYSE:JNJ), Coca-Cola (NYSE:KO), and Procter & Gamble (NYSE:PG), among ot
PlusAI on Track to Launch Factory-Built Commercial Autonomous Trucks Next Year
07:00am, Thursday, 08'th Jan 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)-- #Autonomousdriving--PlusAI, a leader in AI software for autonomous trucks, today provided an update on its commercial readiness metrics, demonstrating continued
IRVINE, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. (Nasdaq: MOBX, “Mobix Labs” or the “Company”), a leading provider of advanced connectivity solutions, today announced the pr
Nvidia's Rubin Chips on Track, CEO Huang Says
01:59am, Tuesday, 06'th Jan 2026
Nvidia's highly anticipated Rubin data center processors are in production and customers will soon be able to try out the technology, according to Chief Executive Officer Jensen Huang. Meanwhile, Adva
China Market Unsettled, But Novo Nordisk's Oral Wegovy May Keep Revenue On Track
11:31am, Monday, 05'th Jan 2026
Novo Nordisk A/S launches oral Wegovy in the U.S. at aggressive introductory pricing, aiming to secure early market share and first-mover advantage. NVO faces imminent semaglutide patent expiry in Chi
NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today
3D Systems Accelerates Growth in Aerospace & Defense with Strategic Investments and Projected Leadership Position
07:30am, Monday, 05'th Jan 2026
Aerospace & Defense on Track to Become Company's Largest Industrial Business in 2026, Supported by Ongoing Investments and Favorable U.S. Policy Tailwinds Aerospace & Defense on Track to Become Compan
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer's Disease Psychosis
07:00am, Monday, 05'th Jan 2026
SAN FRANCISCO and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (“MapLight”) (Nasdaq: MPLT) today announced that the U.S. Food and Drug Administration (FDA) has granted Fas
Shoe Carnival's Transformation Into Shoe Station Is Still On Track
10:43pm, Tuesday, 30'th Dec 2025
Shoe Carnival is executing a turnaround by converting stores to the higher-margin Shoe Station brand, targeting middle-income consumers. Short-term headwinds from rebranding are offset by a $50 millio
Track Group Reports Fiscal 2025 Financial Results
11:00am, Friday, 19'th Dec 2025
NAPERVILLE, Ill., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Track Group, Inc. (OTCQB: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its fiscal year
Merck Cholesterol, Cancer Drugs May Enter FDA Fast-Track Program: Report
11:55am, Thursday, 18'th Dec 2025
The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE: MRK) drugs with potential blockbuster sales.
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma
06:00am, Thursday, 18'th Dec 2025
SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration
Rivian's Stock Is On Track for Its Best Year Since Going Public. Can It Continue Its Rally in 2026?
08:05pm, Wednesday, 17'th Dec 2025
Shares of Rivian have been rallying after the company posted better-than-expected results. It also held an event highlighting its artificial intelligence (AI) efforts.
FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug
09:46am, Wednesday, 17'th Dec 2025
Adagene jumps 13.8% after the FDA grants Fast Track Status to muzastotug with pembrolizumab for MSS metastatic colorectal cancer.
Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions and fill an unmet need
Sign In
Buy TRCK